Search results
Postpartum Bipolar Disorder: Symptoms, Treatment, Outlook
Healthline· 7 days agoIf you have bipolar disorder, it may get worse after you have a baby, and you may experience...
Anosognosia: Everything You Need to Know
Verywell Health via Yahoo News· 2 days agoSomeone living with anosognosia may not be aware they have an illness and need treatment. They might doubt their diagnosis, attribute signs and symptoms...
Signs and Symptoms of Diabetes Insipidus
Health via Yahoo News· 20 hours agoIf you have symptoms of diabetes insipidus with no other clear explanation, discuss the symptoms with your healthcare provider. They can order lab and...
Schizoid vs. Schizotypal Personality Disorders
Verywell Mind via Yahoo News· 2 days agoTreatment Options People with schizoid or schizotypal personality disorder might only seek treatment at the behest...
Link between depression and cardiovascular disease explained: They partly develop from same gene...
Medical Xpress· 8 hours agoFor example, people with depression run a greater risk of CVD, while effective early treatment for...
Avoidance Predicts Worse Long-term Outcomes in OCD
Medscape· 2 days agoBehavioral avoidance could limit the long-term of a widely used treatment for obsessive compulsive disorder, a new analysis shows.
The Best Ashwagandha Supplements, According to Health Experts
Eating Well via Yahoo News· 5 days agoWhat to know: This softgel contains rhodiola, which should not be taken by those with bipolar...
Understanding Benzodiazepines and How They Work
Verywell Health via Yahoo News· 23 hours agoBenzodiazepines (also known as benzos) are a class of medications used to treat anxiety disorders, seizures, insomnia, and other health conditions. While...
Reviva Pharmaceuticals (NASDAQ:RVPH) vs. Bristol-Myers Squibb (NYSE:BMY) Head to Head Survey
ETF DAILY NEWS· 9 hours agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) and Reviva Pharmaceuticals (NASDAQ:RVPH – Get Free Report) are both medical companies, but which is the better investment? We will compare the ...
BioXcel Therapeutics Announces Plan for Evaluating BXCL501 in the At-Home Setting to Expand Its...
Morningstar· 3 days agoThe Company’s plan to conduct this trial using a 120 mcg dose is based on feedback received from the U.S. Food and Drug Administration (FDA...
